NCT02544074View on ClinicalTrials.gov

Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)

CompletedOBSERVATIONAL
Enrollment

69

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

November 13, 2024

Study Completion Date

November 13, 2024

Conditions
Mild Cognitive ImpairmentDementia
Interventions
BEHAVIORAL

neuropsychological testing

standard neuropsychological testing including brief standardized assessments

BEHAVIORAL

eSAGE testing

Neuropsychological testing including the eSAGE tablet and eSAGE smartphone

Trial Locations (1)

43221

The Ohio State University, Columbus

All Listed Sponsors
collaborator

Brain Test, Inc.

INDUSTRY

lead

Ohio State University

OTHER

NCT02544074 - Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE) | Biotech Hunter | Biotech Hunter